Bruker vs Revvity
Bruker reported revenue of $3.4 billion in fiscal 2025, 1.2 times Revvity's $2.9 billion in fiscal 2025. Bruker's revenue grew 2.1% in its latest year, and Revvity's grew 3.7%. Bruker had an operating margin of 2.0%, against 12.5% at Revvity. Free cash flow was $43 million at Bruker and $509 million at Revvity. Their fiscal years end in different months (December 31 and December 28), so the periods don't line up exactly.
Side by side
| Bruker | Revvity | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 28, 2025 |
| Revenue | $3.4B | $2.9B |
| Revenue growth | 2.1% | 3.7% |
| Revenue growth a year, last 5 years | 11.6% | −5.5% |
| Gross margin | 45.9% | — |
| Operating margin | 2.0% | 12.5% |
| Net margin | −0.2% | 8.4% |
| Free cash flow | $43M | $509M |
| Free cash flow margin | 1.3% | 17.8% |
| Return on capital | 0.9% | 3.3% |
| Net debt to EBITDA | 5.5x | 3.0x |
| Dividends and buybacks | $33M | $854M |
| Change in diluted share count | 1.5% | −5.1% |
| Last close | $58.23 | $160.39 |
| P/E at the last close | — | 76.7× |
| Insider trades, last 12 months | sold $3.6 million | sold $6.0 million |
| Piotroski F-score | 4 of 9 | 5 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
BrukerRevvity
Operating margin
Percent of revenue
BrukerRevvity
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
BrukerRevvity